iDose TR with Cataract Surgery for Glaucoma or OHT
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
- Age
- 45 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 132 (estimated)
- Sponsor
- Glaukos Corporation · Industry
This trial is looking for people with cataracts who also have glaucoma or high eye pressure. Participants will receive an iDose TR implant during cataract surgery to see if it helps lower eye pressure more than surgery alone.
You may be able to join if
- I have been diagnosed with cataracts that need surgery.
- I have been diagnosed with glaucoma or high eye pressure.
You may not be able to join if
- I have active inflammation or swelling in my cornea.
- I have retinal disorders that are not related to glaucoma.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Loading trial locations…